Zeng-Yan Huang1,2, Ling-Jun Wang1,2, Jia-Jia Wang1,2, Wen-Jun Feng1, Zhong-Qi Yang1,2, Shi-Hao Ni1,2, Yu-Sheng Huang1,2, Huan Li1,2, Yi Yang1,2, Ming-Qing Wang3,4, Rong Hu3, Heng Wan5, Chan-Juan Wen6, Shao-Xiang Xian1,2, Lu Lu1,2. 1. The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, China. 2. Lingnan Medical Research Center, Guangzhou University of Chinese Medicine, Guangzhou, China. 3. School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China. 4. Peninsula School of Medicine, University of Plymouth, Plymouth, UK. 5. Department of Endocrinology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China. 6. Department of Radiology, Nan Fang Hospital of Southern Medical University, Guangzhou, China.
Abstract
BACKGROUND AND PURPOSE: Liquorice is the root of Glycyrrhiza glabra, which is a popular food in Europe and China that has previously shown benefits for skeletal fatigue and nutrient metabolism. However, the mechanism and active ingredients remain largely unclear. The aim of this study was to investigate the active ingredients of liquorice for muscle wasting and elucidate the underlying mechanisms. EXPERIMENTAL APPROACH: RNA-Seq and bioinformatics analysis were applied to predict the main target of liquorice. A machine learning model and a docking tool were used to predict active ingredients. Isotope labelling experiments, immunostaining, Western blots, qRT-PCR, ChIP-PCR and luciferase reporters were utilized to test the pharmacological effects in vitro and in vivo. The reverse effects were verified through recombination-based overexpression. KEY RESULTS: The liposoluble constituents of liquorice improved muscle wasting by inhibiting protein catabolism and fibre atrophy. We further identified FoxO1 as the target of liposoluble constituents of liquorice. In addition, hispaglabridin B (HB) was predicted as an inhibitor of FoxO1. Further studies determined that HB improved muscle wasting by inhibiting catabolism in vivo and in vitro. HB also markedly suppressed the transcriptional activity of FoxO1, with decreased expression of the muscle-specific E3 ubiquitin ligases MuRF1 and Atrogin-1. CONCLUSIONS AND IMPLICATIONS: HB can serve as a novel natural food extract for preventing muscle wasting in chronic kidney disease and possibly other catabolic conditions.
BACKGROUND AND PURPOSE: Liquorice is the root of Glycyrrhiza glabra, which is a popular food in Europe and China that has previously shown benefits for skeletal fatigue and nutrient metabolism. However, the mechanism and active ingredients remain largely unclear. The aim of this study was to investigate the active ingredients of liquorice for muscle wasting and elucidate the underlying mechanisms. EXPERIMENTAL APPROACH: RNA-Seq and bioinformatics analysis were applied to predict the main target of liquorice. A machine learning model and a docking tool were used to predict active ingredients. Isotope labelling experiments, immunostaining, Western blots, qRT-PCR, ChIP-PCR and luciferase reporters were utilized to test the pharmacological effects in vitro and in vivo. The reverse effects were verified through recombination-based overexpression. KEY RESULTS: The liposoluble constituents of liquorice improved muscle wasting by inhibiting protein catabolism and fibre atrophy. We further identified FoxO1 as the target of liposoluble constituents of liquorice. In addition, hispaglabridin B (HB) was predicted as an inhibitor of FoxO1. Further studies determined that HB improved muscle wasting by inhibiting catabolism in vivo and in vitro. HB also markedly suppressed the transcriptional activity of FoxO1, with decreased expression of the muscle-specific E3 ubiquitin ligases MuRF1 and Atrogin-1. CONCLUSIONS AND IMPLICATIONS: HB can serve as a novel natural food extract for preventing muscle wasting in chronic kidney disease and possibly other catabolic conditions.
Authors: Dino Oglic; Steven A Oatley; Simon J F Macdonald; Thomas Mcinally; Roman Garnett; Jonathan D Hirst; Thomas Gärtner Journal: Mol Inform Date: 2018-02-01 Impact factor: 3.353
Authors: David S Waddell; Leslie M Baehr; Jens van den Brandt; Steven A Johnsen; Holger M Reichardt; J David Furlow; Sue C Bodine Journal: Am J Physiol Endocrinol Metab Date: 2008-07-08 Impact factor: 4.310